Understanding eGFR in the clinical context: who does and does not need referral?

By Dr. Monica Beaulieu on August 9, 2010

Identifying patients with eGFR<60ml/min remains important to avoid potential risks, but it is becoming clear that referring all those patients to nephrologists is neither appropriate nor efficient.

New study on the use of erythropoietin stimulating agents in chronic kidney disease has made us evaluate the risk-benefit of ESA’s in CKD patients not on dialysis.

By Dr. Monica Beaulieu on June 14, 2010

The evidence strongly suggests that there is little to no benefit gained by raising the Hb over > 100g/L (and perhaps even lower) in diabetic patients with CKD not on dialysis.

Visit UBC CPD at ubccpd.ca

UBC CPD website

View all CPD learning activities: virtual, in-person and hybrid conferences, workshops, webinars, online modules, customized community courses, simulation hands-on courses, coaching, mentoring, personalized learning, recordings, and more.

Visit UBC CPD ↗

This field is for validation purposes and should be left unchanged.